Pentetate zinc trisodium (hameln pharma plus gmbh)


Welcome to the PulseAid listing for the Pentetate zinc trisodium drug offered from hameln pharma plus gmbh. This Lead Chelating Activity [MoA],Lead Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: hameln pharma plus gmbh
NON-PROPRIETARY NAME: Pentetate zinc trisodium
SUBSTANCE NAME: PENTETATE ZINC TRISODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lead Chelating Activity [MoA],Lead Chelator [EPC]
ROUTE: INTRAVENOUS; RESPIRATORY (INHALATION)
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-08-11
END MARKETING DATE: 0000-00-00


Pentetate zinc trisodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPentetate zinc trisodium from hameln pharma plus gmbh
LABELER NAME: hameln pharma plus gmbh
DEA SCHEDULE:
ACTIVE STRENGTH: 1000(mg/5mL)
START MARKETING DATE: 2004-08-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70651-002_c2cb9945-6286-4857-96b0-382ae962b537
PRODUCT NDC: 70651-002
APPLICATION NUMBER: NDA021751

Other PENTETATE ZINC TRISODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
hameln pharma plus gmbhPentetate zinc trisodium